Touax SCA | Small-cap | Industrials

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 611.4M
Total Liabilities 458.2M
Shareholders Equity 153.3M
Debt to Equity 2.99

Cash Flow Metrics

Revenue & Profitability Trend

Touax SCA Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i198.5M195.4M210.6M167.9M163.4M
Cost of Goods Sold i112.5M116.9M116.6M63.7M77.4M
Gross Profit i86.0M78.5M94.0M104.2M86.0M
Gross Margin % i43.3%40.2%44.6%62.1%52.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-----
Other Operating Expenses i91.0K424.0K2.1M338.0K153.0K
Total Operating Expenses i91.0K424.0K2.1M338.0K153.0K
Operating Income i54.7M53.1M68.2M63.5M62.4M
Operating Margin % i27.6%27.2%32.4%37.8%38.2%
Non-Operating Items
Interest Income i555.0K265.0K113.0K22.0K18.0K
Interest Expense i22.0M20.7M15.3M11.8M11.9M
Other Non-Operating Income-----
Pre-tax Income i4.7M7.3M15.7M16.8M10.0M
Income Tax i1.6M1.5M6.3M1.0M1.0M
Effective Tax Rate % i34.0%20.2%40.1%6.2%10.1%
Net Income i4.5M5.8M9.4M15.8M8.8M
Net Margin % i2.3%3.0%4.5%9.4%5.4%
Key Metrics
EBITDA i63.5M56.6M60.9M51.7M44.5M
EPS (Basic) i€0.56€0.52€1.07€1.79€0.84
EPS (Diluted) i€0.56€0.52€1.07€1.79€0.84
Basic Shares Outstanding i69642866998194700276370036767002436
Diluted Shares Outstanding i69642866998194700276370036767002436

Income Statement Trend

Touax SCA Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i48.9M39.0M56.0M53.8M62.3M
Short-term Investments i-1.4M724.0K-4.4M
Accounts Receivable i25.4M24.6M28.7M31.0M31.3M
Inventory i104.8M85.0M86.3M95.9M34.9M
Other Current Assets1.2M1.4M724.0K551.0K4.4M
Total Current Assets i186.7M157.2M177.1M194.4M139.5M
Non-Current Assets
Property, Plant & Equipment i596.1M550.1M519.0M466.3M428.1M
Goodwill i13.7M11.5M10.8M10.9M10.8M
Intangible Assets i3.5M1.3M582.0K687.0K628.0K
Long-term Investments2.3M4.6M7.8M1.0M211.0K
Other Non-Current Assets5.8M5.6M1.3M1.7M875.0K
Total Non-Current Assets i424.8M406.3M394.6M358.0M334.5M
Total Assets i611.4M563.4M571.7M552.4M474.0M
Liabilities
Current Liabilities
Accounts Payable i44.2M34.2M12.3M12.6M10.2M
Short-term Debt i178.3M31.9M41.8M68.7M24.7M
Current Portion of Long-term Debt-----
Other Current Liabilities30.3M22.6M29.2M58.9M38.0M
Total Current Liabilities i262.5M99.0M102.1M155.1M83.6M
Non-Current Liabilities
Long-term Debt i187.3M308.5M307.8M226.4M238.2M
Deferred Tax Liabilities i6.7M7.0M7.0M4.7M3.5M
Other Non-Current Liabilities1.1M696.0K749.0K792.0K1.3M
Total Non-Current Liabilities i195.7M316.8M315.9M232.4M243.6M
Total Liabilities i458.2M415.8M418.1M387.4M327.2M
Equity
Common Stock i56.1M56.1M56.1M56.1M56.1M
Retained Earnings i3.9M3.6M7.5M12.6M5.9M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i153.3M147.6M153.7M165.0M146.7M
Key Metrics
Total Debt i365.5M340.4M349.6M295.1M262.9M
Working Capital i-75.8M58.2M75.0M39.3M55.9M

Balance Sheet Composition

Touax SCA Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i4.5M5.8M9.4M15.8M8.8M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-24.3M-5.2M-32.2M-44.1M-8.7M
Operating Cash Flow i1.6M17.6M-7.5M-16.1M11.7M
Investing Activities
Capital Expenditures i-----
Acquisitions i-----
Investment Purchases i----141.0K-20.0K
Investment Sales i---1.1M-
Investing Cash Flow i20.0K1.0K9.0K2.6M-4.0K
Financing Activities
Share Repurchases i-661.0K-803.0K-907.0K-663.0K-369.0K
Dividends Paid i-844.0K-706.0K---
Debt Issuance i66.9M87.6M140.0M48.7M166.8M
Debt Repayment i-48.0M-93.5M-92.7M-22.1M-149.0M
Financing Cash Flow i17.5M-7.4M22.9M30.6M43.1M
Free Cash Flow i15.6M19.3M-1.8M-26.3M-1.6M
Net Change in Cash i19.0M10.2M15.4M17.2M54.8M

Cash Flow Trend

Touax SCA Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 15.71
Forward P/E 4.87
Price to Book 0.47
Price to Sales 0.20
PEG Ratio 4.87

Profitability Ratios

Profit Margin 1.95%
Operating Margin 11.85%
Return on Equity 2.05%
Return on Assets 2.83%

Financial Health

Current Ratio 0.71
Debt to Equity 238.70
Beta 1.67

Per Share Data

EPS (TTM) €0.35
Book Value per Share €11.68
Revenue per Share €28.45

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
toup38.9M15.710.472.05%1.95%238.70
Ayvens S.A 8.0B11.340.717.29%3.17%336.23
Toosla S.A.C.A 2.7M--87.46%-35.09%-4.73
Az Leasing 0--0.00%0.00%-
Schneider Electric 125.0B27.614.6315.97%10.94%61.43
Safran S.A 121.9B28.169.2334.75%14.71%37.14

Financial data is updated regularly. All figures are in the company's reporting currency.